Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative proteomics in acute myeloid leukemia.
Luczak M, Kaźmierczak M, Hadschuh L, Lewandowski K, Komarnicki M, Figlerowicz M. Luczak M, et al. Among authors: lewandowski k. Contemp Oncol (Pozn). 2012;16(2):95-103. doi: 10.5114/wo.2012.28787. Epub 2012 May 29. Contemp Oncol (Pozn). 2012. PMID: 23788862 Free PMC article.
Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia.
Styczyński J, Gil L, Czyżewski K, Kołodziej B, Kuryło-Rafińska B, Lewandowski K, Gniot M, Lewandowska M, Komarnicki M, Wysocki M. Styczyński J, et al. Among authors: lewandowski k. Contemp Oncol (Pozn). 2012;16(3):210-4. doi: 10.5114/wo.2012.29286. Epub 2012 Jul 6. Contemp Oncol (Pozn). 2012. PMID: 23788881 Free PMC article.
Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase inhibitor treatment.
Gniot M, Lewandowski K, Ratajczak B, Lewandowska M, Lehmann-Kopydłowska A, Jarmuż-Szymczak M, Komarnicki M. Gniot M, et al. Among authors: lewandowski k. Cancer Genet. 2014 Oct-Dec;207(10-12):503-10. doi: 10.1016/j.cancergen.2014.10.003. Epub 2014 Oct 15. Cancer Genet. 2014. PMID: 25496750
The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms.
Borowczyk M, Wojtaszewska M, Lewandowski K, Gil L, Lewandowska M, Lehmann-Kopydłowska A, Kroll-Balcerzak R, Balcerzak A, Iwoła M, Michalak M, Komarnicki M. Borowczyk M, et al. Among authors: lewandowski k. Thromb Res. 2015 Feb;135(2):272-80. doi: 10.1016/j.thromres.2014.11.006. Epub 2014 Nov 15. Thromb Res. 2015. PMID: 25559461
The JAK2 V617F mutational status and allele burden--authors' reply.
Borowczyk M, Wojtaszewska M, Lewandowski K, Gil L, Lewandowska M, Lehmann-Kopydłowska A, Kroll-Balcerzak R, Balcerzak A, Iwoła M, Michalak M, Komarnicki M. Borowczyk M, et al. Among authors: lewandowski k. Thromb Res. 2015 Sep;136(3):691-2. doi: 10.1016/j.thromres.2015.07.006. Epub 2015 Jul 10. Thromb Res. 2015. PMID: 26216656 No abstract available.
482 results